LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 21 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $84,000 | -74.9% | 27,084 | -56.7% | 0.00% | -75.0% |
| Q1 2022 | $334,000 | +9.5% | 62,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $305,000 | -44.8% | 62,500 | 0.0% | 0.00% | -42.9% |
| Q3 2021 | $553,000 | -28.9% | 62,500 | -26.8% | 0.01% | -22.2% |
| Q2 2021 | $778,000 | -62.0% | 85,360 | -31.7% | 0.01% | -65.4% |
| Q1 2021 | $2,048,000 | – | 125,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |